Serum Raman spectroscopy can be used to screen patients with early rheumatoid arthritis

J Biophotonics. 2023 Jun;16(6):e202200368. doi: 10.1002/jbio.202200368. Epub 2023 Feb 19.

Abstract

In this study, Raman spectroscopy was used to analyze the serum of patients with early rheumatoid arthritis (RA), and to explore the screening value of Raman spectroscopy in patients with early RA. A total of 216 patients were included in the study. Fasting venous blood was collected for routine biochemical detection, and the remaining samples were tested by serum Raman spectroscopy. Support vector machine was used for model building and training. The area under the curve (AUC) values of the model were as follows: (1) healthy group versus early RA group: 0.860, (2) healthy group versus non-early RA group: 0.903, and (3) early RA group versus non-early RA group: 0.918. This study shows that serum Raman spectroscopy has a good ability to screen RA and can be staged according to the course of the disease, which can provide new ideas and technical support for the diagnosis or screening of early RA.

Keywords: Raman spectrum; rheumatoid arthritis; rheumatoid factor; screening; support vector machine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid* / diagnosis
  • Biomarkers
  • Humans
  • Sensitivity and Specificity
  • Spectrum Analysis, Raman*

Substances

  • Biomarkers